ARSA and metabolic dysfunction-associated steatohepatitis: In this work, we identify ARSA as a NASH-inducible hepatokine and powerful modulator of hepatic sulfatide and lysophospholipid metabolism, skeletal muscle insulin action, and whole-body glycemic control.